- Grom Social Enterprises (GROM) -28% on pricing $3M private placement.
- Precigen (PGEN) -21% on pricing $75M common stock offering.
- Baudax Bio (BXRX) -12%.
- PolyPid (PYPD) -12%.
- Lytus Technologies (LYT) -12%.
- MicroCloud Hologram (HOLO) -11%.
- Intuitive Surgical (ISRG) -10% on Q4 earnings release.
- Intelligent Bio Solutions (INBS) -8%.
- Li-Cycle Holdings (LICY) -7% after Morgan Stanley turns bearish on 2023 setup.
- Blue Apron Holdings (APRN) -7%.
- Fisker (FSR) -6% after Morgan Stanley downgrade based on slower EV adoption expectations.
- Redfin (RDFN) -6%.
- Capricor Therapeutics (CAPR) -6% after notifies positive 18-month results from ongoing HOPE-2 open label extension study of CAP-1002 in Duchenne muscular dystrophy patients.
- Argo Blockchain (ARBK) -5%.
- Can-Fite BioPharma (CANF) -5%.
- SatixFy Communications (SATX) -5%.
- T Stamp (IDAI) -5%.